Bradycardia, a condition characterized by an abnormally slow heart rate, poses significant challenges in terms of diagnosis and treatment. While it is a concern world-wide, low- and middle-income countries (LMICs) face substantial barriers in accessing appropriate bradycardia therapy. This article aims to explore the global aetiology and incidence of bradycardia, compare the prevalence and management of the condition in high-income countries versus LMICs, identify the key reasons behind the disparities in access to bradycardia therapy in LMICs, and emphasize the urgent need to address these disparities to ensure equitable healthcare on a global scale.
Keywords: Access to care; Bradycardia; Low- and middle-income countries (LMICs); Pacemaker therapy; Sinus node disfunction.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.